Everence Capital Management Inc Alkermes Plc. Transaction History
Everence Capital Management Inc
- $1.54 Billion
- Q4 2024
A detailed history of Everence Capital Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Everence Capital Management Inc holds 9,540 shares of ALKS stock, worth $300,796. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,540
Previous 18,380
48.1%
Holding current value
$300,796
Previous $514,000
46.69%
% of portfolio
0.02%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
359Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$918 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$598 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$410 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$399 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$290 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.18B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...